PHISOHEX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Phisohex, and when can generic versions of Phisohex launch?
Phisohex is a drug marketed by Sanofi Aventis Us and is included in two NDAs.
The generic ingredient in PHISOHEX is hexachlorophene. There are seven drug master file entries for this compound. Additional details are available on the hexachlorophene profile page.
Summary for PHISOHEX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 80 |
Clinical Trials: | 1 |
Patent Applications: | 3,373 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PHISOHEX at DailyMed |
Recent Clinical Trials for PHISOHEX
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Natividad Medical Center | N/A |
Anatomical Therapeutic Chemical (ATC) Classes for PHISOHEX
US Patents and Regulatory Information for PHISOHEX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi Aventis Us | PHISOHEX | hexachlorophene | EMULSION;TOPICAL | 006882-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sanofi Aventis Us | PHISOHEX | hexachlorophene | EMULSION;TOPICAL | 008402-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |